Adamas Pharmaceuticals' Debt - II Round

Adamas Pharmaceuticals raised a round of funding on August 18, 2007.

Adamas, formerly NeuroMolecular Pharmaceuticals, is a pharmaceutical company focused on developing small molecule, advantaged therapeutics to treat neurological and infectious diseases, including infl…

Articles about Adamas Pharmaceuticals' Debt - II Round: